Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know
Werewolf Therapeutics分析师评级的关键见解：你需要知道的
In the latest quarter, 5 analysts provided ratings for Werewolf Therapeutics (NASDAQ:HOWL), showcasing a mix of bullish and bearish perspectives.
在最近一个季度中，有5位分析师为狼人疗法（纳斯达克股票代码：HOWL）提供了评级，显示了看涨和看跌的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Werewolf Therapeutics and provided 12-month price targets. The average target is $13.8, accompanied by a high estimate of $15.00 and a low estimate of $12.00. Observing a downward trend, the current average is 8.0% lower than the prior average price target of $15.00.
分析师最近对Werewolf Therapeutics进行了评估，并提供了12个月的目标股价。平均目标为13.8美元，最高估计值为15.00美元，低估值为12.00美元。观察下降趋势，当前的平均价格比之前的平均目标价15.00美元低8.0％。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The standing of Werewolf Therapeutics among financial experts is revealed...
通过对近期分析师行为...
登录免费看全文
登录/注册